Compensation award — excluded from discretionary-purchase analysis.
Loading…
Traded Jun 3, 2026 · Filed Jun 3, 2026
A board member of Insulet Corporation spent $497K of their very own money to buy Insulet Corporation shares. 1 other person at Insulet Corporation bought some too, in the same month. Their pile of Insulet Corporation shares grew by 50%.
Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell
open market purchase
Code P — open-market or private purchase
~$497,490
Shares × reported transaction price
$100K–$500K
+50.0%
Purchase shares ÷ estimated pre-transaction holdings, from the filing
Not enough history to judge
Confirmed open-market purchases by the same insider in the available history
2 distinct insiders in 30 days
Distinct insiders at the same issuer with confirmed open-market purchases
28 days after results of May 6, 2026, 63 days before results of Aug 5, 2026
Results dates are the company's own 8-K (Item 2.02). Many companies only let insiders trade in a window after results
Closed at $143.30 on Jun 3, 2026, within 1% of its 52-week low, after a 25% drop over the previous 30 trading days
52-week range $142.43 (Jun 2, 2026) to $352.82 (Sep 9, 2025), 0% of the way up, from 251 adjusted closes. 30 trading days earlier: $192.33 on Apr 21, 2026. Describes the past only, not a forecast
None found in footnotes
Only flagged when a footnote says so; never inferred
| After | Stock | S&P 500 | Difference |
|---|---|---|---|
| 7 days | +1.9% | -2.5% | +4.5% |
| 30 days | +9.1% | -0.8% | +9.9% |
| 90 days | +1.2% | +1.1% | +0.1% |
Past results only. Not a forecast.
Compensation award — excluded from discretionary-purchase analysis.
Compensation award — excluded from discretionary-purchase analysis.
A board member of Insulet Corporation spent $400K of their very own money to buy Insulet Corporation shares. 1 other person at Insulet Corporation bought some too, in the same month. It was the first time in 6 months that they bought.